Podcasts

Dr. Akhilesh Sharma, Senior VP, Dr. Reddy's Laboratories on Target Engagement, Translational Strategies and Timelines in Early Phase Clinical Trials: Dr. Akhilesh Sharma, Senior Vice President and Global Head of Global Medical Affairs at Dr. Reddy's Laboratories, joins Pharma IQ to discuss emerging trends in early phase clinical studies and the latest strategies to reduce timelines and prevent early and late phase failures. listen now

Discover how to take Time and Cost out of Clinical Trials in 11 minutes: Nancy Widener, Executive Director, Clinical Science and Operations at Bristol Myers Squibb delivers practical tips on how to eliminate errors in early development, thus saving millions of dollars and years of research listen now

How to Deliver Cost Effective Pharmaceutical Global Artwork: Labelling and Artwork are still the highest causes of the recall of pharmaceutical products. Andrew Love, Vice President at Pharmaceutical Advisory Services, Be4ward Ltd, talks to Pharma IQ about his hopes to resolve these issues in the bid of patient safety. listen now

Insights into Discovery of Structured Data: On behalf of Legal IQ, Jim Vint, Managing Director at Navigant, interviews Patrick Oot, Co-Founder and GC, Electronic Discovery Institute, Special Counsel, Electronic Discovery at US Securities and Exchange Commission about the latest developments in Information Governance. listen now

How to Dodge Common Pitfalls Leading to Prosecution in the Pharma Industry: Joshua Holzer, Chief Compliance Counsel for Global Trade, Pfizer Inc, joins Pharma IQ to discuss common concerns of pharma companies when it comes to compliance regulatory investigations and strategies that in house counsel can use to help their company protect itself and better manage compliance. listen now

The Pharma Supply Chain: Developing and Implementing Strategies for Aviation Security: The distribution of clinical supplies can be a challenge for any trial. Paul Wiberg-Jørgensen, Vice President, Logistics, Statens Serum Institute, discusses what steps the SSI is taking to overcome the challenges of clinical trial supply distribution and developing and implementing strategies to comply with EU Regulation 185/2010 on “Detailed Measures to Implement the Common Basic Standards on Aviation Security." listen now

Eli Lilly Face Challenges involved in Complying to Serialisation Requirements with Success: Eli Lilly's experience of complying with strict Turkish serialisation requirements has taught them how to handle future implementation of serialisation globally in a more effective manner, explains Hicham Safine, Europe/AMEA/CIS Quality Consultant at Eli Lilly. And just how will the Falsified Medicine Directive impact the pharmaceutical industry when fully implemented? listen now

Identifying Formulations to Progress Compounds Solubility: Solving solubility problems is one of the leading challenges in drug development, as poorly soluble compounds are estimated to account for 60% of compounds. Preclinical development encompasses the activities that link the drug discovery process in the lab to initiation of human clinical trials. Anuj Kuldipkumar, PhD, Scientist II at Vertex Pharmaceuticals, identifies steps to take in developing toxicology and safety studies to identify potential target organs for adverse effects. listen now

Steps to Expediting Time-to-Market for Insoluble Drug Candidates: Improving the solubility of new chemical entities has proven to be one of the biggest hurdles to overcome in pharmaceutical drug development, and companies are always looking for new strategies for increasing bioavailability of new drugs. Many companies are working to leverage new methods to measure, predict and improve drug solubility. However, understanding fundamental differences between thermodynamic and kinetic solubility is key for the development of drug candidates with improved solubility and suitable stability. Alphonso Higuera, PhD, Senior Research Scientist (Preformulation), Forest Research Institute explains listen now

Lessons Learnt: A Multi-Partner Approach to Clinical Trials: With several thousand clinical trials currently running in Scandinavia, Nordic biotech and pharma companies, CROs and research institutions are increasingly extending their reach into other geographic regions. Maria Ohlander, Head of Clinical Development at Karo Bio, shares valuable experiences of the multi-partner approach Karo Bio took to develop compounds with an Indian partner and 3 other CROs. listen now